BackgroundDrug-induced immune hemolytic anemia (DIIHA) is a rare but potentially life-threatening drug-related complication. There are no previous reports of pemetrexed plus cisplatin as first-line chemotherapy for non-small cell lung cancer. resulting in DIIHA. Case presentationIn this report. https://www.marketingjeunesse.com/product-category/razorless-cream/